title: Cutaneous Mycobacterium kansasii infection in a patient with AIDS post initiation of antiretroviral therapy.
abstract: The HIV pandemic has resulted in unique clinical presentations in patients, and their diagnosis and management pose challenges to physicians in the developing world. Due to limited resources and difficulties in laboratory diagnosis, most physicians treat according to the most likely etiological agent that might be causing the disease. In South Africa, when acid-fast bacilli are detected, anti-tuberculous treatment is commenced. However, it must be realized that not all acid-fast bacilli are Mycobacterium tuberculosis, and that there are nontuberculous mycobacteria that can cause infections. Clinicians should work closely with the medical microbiologist when unique cases arise to ensure optimal microbial detection, identification, and patient management. This paper describes a very rare case of self-resolving cutaneous Mycobacterium kansasii infection following the initiation of antiretroviral therapy and potentially associated with immune reconstitution inflammatory syndrome.
authors.affiliation: Inkosi Albert Luthuli Central Hospital, Durban, South Africa. momitha@telkomsa.net
authors.forename: Mohammed
authors.initials: M
authors.lastname: Mitha
authors.forename: Preneshni
authors.initials: P
authors.lastname: Naicker
authors.forename: Jantjie
authors.initials: J
authors.lastname: Taljaard
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000175:diagnosis; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000382:microbiology; D019909:Mycobacterium kansasii / Q000302:isolation & purification*; D017192:Skin Diseases, Bacterial / Q000175:diagnosis* / Q000382:microbiology; D013019:South Africa
chemical_list: D019380:Anti-HIV Agents